After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Physicians recommend that patients with chronic obstructive pulmonary disease (COPD) quit smoking and use steroids, antibiotics and other drugs to manage the sometimes debilitating symptoms. However, ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

But Verona is off to a strong start as Ohtuvayre generated sales of $42 million in 2024, the company reported on Tuesday.

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...